Difficulty: Medium
Average Score: 73%
Practice
A 68-year-old man with a 6-month history of progressive pill-rolling tremors of the hands, urinary incontinence, and cogwheel rigidity presents to his primary care physician for evaluation. Physical examination confirms the earlier findings. Which of the following is a therapeutic goal for this condition?
Correct answer
A
Rationale
The correct answer is A) Antagonizing the excitatory effect of cholinergic neurons. In the case described, the patient is presenting with symptoms consistent with Parkinson's disease, characterized by a deficiency of dopamine in the basal ganglia. The therapeutic goal in Parkinson's disease is to rebalance neurotransmitters, particularly by increasing dopamine levels or antagonizing the effects of other neurotransmitters like acetylcholine.
Option B) Dynamic physical and occupational therapy is beneficial for managing symptoms in Parkinson's disease, but it is not a primary therapeutic goal aimed at addressing the underlying neurotransmitter imbalance.
Option C) Lower concentrations of CNS dopamine would exacerbate the symptoms of Parkinson's disease, as the primary issue in this condition is a decrease in dopamine levels.
Option D) Restoring dopamine concentration in the cerebellum is not the primary therapeutic goal in Parkinson's disease, as the area primarily affected is the basal ganglia, not the cerebellum.
Understanding the pharmacology of CNS drugs is crucial for healthcare providers to make informed decisions about the most appropriate treatments for neurological conditions. In this case, targeting the cholinergic neurons to rebalance neurotransmitter activity is essential for managing the symptoms of Parkinson's disease effectively.
Option B) Dynamic physical and occupational therapy is beneficial for managing symptoms in Parkinson's disease, but it is not a primary therapeutic goal aimed at addressing the underlying neurotransmitter imbalance.
Option C) Lower concentrations of CNS dopamine would exacerbate the symptoms of Parkinson's disease, as the primary issue in this condition is a decrease in dopamine levels.
Option D) Restoring dopamine concentration in the cerebellum is not the primary therapeutic goal in Parkinson's disease, as the area primarily affected is the basal ganglia, not the cerebellum.
Understanding the pharmacology of CNS drugs is crucial for healthcare providers to make informed decisions about the most appropriate treatments for neurological conditions. In this case, targeting the cholinergic neurons to rebalance neurotransmitter activity is essential for managing the symptoms of Parkinson's disease effectively.